Recensioni verificate Soddisfatta del servizio.
Personale disponibile e gentile. Lo consiglio a tutti ...
Cliente Sorgente Genetica
logomysorgente

02  4948  5291

  • Cos'è AURORA

    Aurora è il test di screening prenatale di ultima generazione 
    sicuro, affidabile,
    veloce e precoce

  • Sicuro

    Grazie a un semplice prelievo di sangue materno
    eviti il rischio di aborto di tecniche invasive come amniocentesi o villocentesi

  • Affidabile

    Oltre il 99,9% di affidabilità nel rilevare
    la trisomia 21, responsabile
    della Sindrome di Down

  • Precoce e veloce

    icona svegliaIndividuare precocemente la presenza di anomalie cromosomiche è fondamentale:
    puoi effettuare Aurora dalla 10ª settimana

    icona documentoIl test è veloce: risultati in 7-10 giorni lavorativi con la percentuale di test da ripetere più bassa del mercato: 0,1%

  • La serenità della mamma
    in 3 semplici passi

    icotelefona

    Prenota il test

    icoesami

    Fai un prelievo di sangue

    icoginecologo

    Leggi i risultati

  • Test diagnosi prenatale non invasivo
  • 151126 banner Aurora mobile 01
  • 151126 banner Aurora mobile 02
  • 151126 banner Aurora mobile 03
  • slide mobile03
cover cartoon
cover venturetti

Ultime notizie dal mondo della genetica


A lantern to improve the diagnosis of lysosomal storage diseases

Lysosomal storage diseases are among the less known rare genetic diseases. Doctors often attribute symptoms to more known diseases, delaying the diagnosis. A new program, The Lantern Project, aims to solve this problem. The project will offer genetic tests for the diagnosis of lysosomal storage diseases, such as Fabry's syndrome or Gaucher's disease.

It is estimated that there are about 10,000 cases of undiagnosed lysosomal storage diseases. Sometimes, the diagnosis requires years and exhausting pilgrimages from one doctor to another. For Fabry's disease, the average diagnosis period is around 15 years. Among the reasons is the inability to access comprehensive diagnostic tests, which also include the genetic aspect. The Lantern Project aims to address this problem.

The aim of the project is to facilitate the diagnosis for the many US doctors and patients. In particular, the project will focus on those who fear suffering from the disease of Gaucher, Pompe, Niemann-Pick and Fabry. In addition to genetic testing, tests for enzyme levels and tests for some muscular dystrophies will be available.

The project focuses on the possibilities offered by next-generation sequencing technology. The new method is in fact faster and cheaper than the previous ones, since it allows to analyze several genes at the same time. As a result, it is possible to test each patient for various lysosomal storage diseases in a short time.

Source: fabrydiseasenews.com

Link social

Link social